Nicholas Corcoran - 24 Feb 2025 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role
SVP of Supply Chain and Operations, Exhibit List: Exhibit 24 - Power of Attorney
Signature
By: /s/ Gerardo Hernandez, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
24 Feb 2025
Net transactions value
$0
Form type
4
Filing time
26 Feb 2025, 18:12:20 UTC
Previous filing
29 Aug 2024
Next filing
04 Mar 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMDX Common Stock Award $0 +12,676 +60% $0.000000 33,781 24 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMDX Stock Option (Right to Buy) Award $0 +19,079 $0.000000 19,079 24 Feb 2025 Common Stock 19,079 $77.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 12,676 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2 The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 24, 2025 until the option is fully vested on February 24, 2029, subject to continued service.

Remarks:

SVP of Supply Chain and Operations, Exhibit List: Exhibit 24 - Power of Attorney